CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Go back to CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 2.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.95 | 52 Week High | $24.68 | |||
| Open | $2.95 | 52 Week Low | $9.10 | |||
| Day High | $2.95 | P/E | N/A | |||
| Day Low | $2.95 | EPS | $0.00 | |||
| Volume | 51,771 | |||||
